I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

APVRS 2025

We will be contributing to topics related to
-
02:00 AM
Duration 24hrs Manila, Philippines
​Indirect Comparison of the Relative Effectiveness of Faricimab▼ vs Aflibercept 8 mg in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Adrian Koh
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 24hrs Manila, Philippines
Automated Quantification of Retinal Fluid in Patients With Diabetic Macular Edema: Analysis of Faricimab▼ vs Aflibercept in YOSEMITE/RHINE
Simon Szeto
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 24hrs Manila, Philippines
Comparative Efficacy of Faricimab▼ for the Treatment of Diabetic ​Macular Edema at 1 and 2 Years: ​A Systematic Literature Review ​and Network Meta-Analysis
Colin Tan
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 24hrs Manila, Philippines
Assessing a 36-Week Refill-Exchange Regimen for the PDS in Patients With Up to 2 Years’ Diagnosis of nAMD: Phase 3b Sightspire Trial
Thanapong Somkijrungroj
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 24hrs Manila, Philippines
Impact of Continuous vs As-Needed Treatment in Bilateral Diabetic Macular Edema: Efficacy and Safety Outcomes in Port Delivery Platform−Treated Study Eyes vs Intravitreal Injection−Treated Fellow Eyes in the Pagoda Trial
Yi-Ting Hsieh
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:36 PM
Duration 6mins Manila, Philippines
Update on Faricimab▼ for Diabetic Macular Edema: New Clinical Features of Eyes in the RHONE-X Long-Term Extension Study
Young Hee Yoon
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:00 PM
Duration 6mins Manila, Philippines
Four-Year Outcomes of Faricimab▼ in nAMD: Safety and Efficacy Results From the AVONELLE-X Long-Term Extension Trial
Timothy Lai
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:18 PM
Duration 6mins Manila, Philippines
Greater Anatomical Improvements With Faricimab▼ vs Aflibercept 8 Weeks After Injections: A TENAYA/LUCERNE Post Hoc Analysis
Tai-Chi Lin
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 6mins Manila, Philippines
Long-Term Efficacy and Safety of the Port Delivery Platform With Ranibizumab in Patients With nAMD: Results from Ladder- and Archway-to-Portal Studies
Yew Sen Yuen
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:48 PM
Duration 6mins Manila, Philippines
Real-World Outcomes of Faricimab▼ in Patients With nAMD and DME From a Global, Prospective Observational Study: The VOYAGER Study
Voraporn Chaikitmongkol
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:00 PM
Duration 5mins Manila, Philippines
Association of Early Macular Leakage Resolution With Extended Dosing Intervals in Patients With Retinal Vein Occlusion: A Post Hoc Analysis of the BALATON/COMINO Trials
Hemal Mehta
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
05:30 PM
Duration 6mins Manila, Philippines
Faricimab▼ for Polypoidal Choroidal Vasculopathy: 1-Year Results From the Phase 3b/4 SALWEEN Trial
Gemmy Cheung
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:00 PM
Duration 6mins Manila, Philippines
Effectiveness and Safety of Faricimab▼ in Eyes With Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Beyond Year 1: Results From the UK FARWIDE-nAMD and FARWIDE-DME Study
Kenneth Fong
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:00 PM
Duration 6mins Manila, Philippines
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-Naïve nAMD: TENAYA/LUCERNE Post Hoc Analyses
Marie Joan Loy
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:00 PM
Duration 6mins Manila, Philippines
Evaluation of the Role of Interleukin-6 and Vascular Endothelial Growth Factor in Uveitic Macular Edema and Uveitis
Yew Sen Yuen
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:06 PM
Duration 6mins Manila, Philippines
Interleukin-6 Inhibition With Vamikibart in Patients With Uveitic Macular Edema: Data from Phase 3 MEERKAT and SANDCAT Trials
Yew Sen Yuen
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon